INS and Hypoglycemia: This systematic review and network meta-analysis incorporated data from 23 trials to evaluate the efficacy and safety of GLP-1/GIP receptor agonists and weekly insulin analogs, focusing on their effects on HbA1c reduction, fasting plasma glucose (FPG), body weight (BW), incidence of hypoglycemia, and adverse events.